IRIS
RUSSO, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.670
EU - Europa 1.654
NA - Nord America 1.561
SA - Sud America 255
AF - Africa 44
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.486
SG - Singapore 1.178
RU - Federazione Russa 659
CN - Cina 530
IT - Italia 522
VN - Vietnam 401
HK - Hong Kong 270
BR - Brasile 200
DE - Germania 134
IN - India 73
FR - Francia 67
GB - Regno Unito 56
NL - Olanda 55
KR - Corea 50
JP - Giappone 40
FI - Finlandia 35
CA - Canada 30
MX - Messico 28
ES - Italia 27
AR - Argentina 26
BD - Bangladesh 21
PH - Filippine 21
UA - Ucraina 19
PL - Polonia 17
IQ - Iraq 15
EC - Ecuador 11
SE - Svezia 11
ZA - Sudafrica 11
IE - Irlanda 9
PK - Pakistan 9
AT - Austria 8
TH - Thailandia 8
TR - Turchia 8
TW - Taiwan 8
CI - Costa d'Avorio 7
ID - Indonesia 7
LT - Lituania 7
TN - Tunisia 7
BE - Belgio 6
VE - Venezuela 6
EG - Egitto 5
NP - Nepal 5
AU - Australia 4
GR - Grecia 4
JO - Giordania 4
PE - Perù 4
RO - Romania 4
UZ - Uzbekistan 4
BS - Bahamas 3
GT - Guatemala 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
SA - Arabia Saudita 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
NI - Nicaragua 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MZ - Mozambico 1
NE - Niger 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
YT - Mayotte 1
Totale 6.190
Salva come PNG Salva come JPEG
Città #
Singapore 664
San Jose 337
Hong Kong 262
Hefei 222
Ashburn 166
Moscow 138
Beijing 129
Ho Chi Minh City 123
Chandler 114
Naples 104
Hanoi 85
Santa Clara 64
Los Angeles 56
Lauterbourg 51
Munich 51
Milan 50
The Dalles 46
Seoul 43
Rome 42
Kochi 38
Tokyo 36
New York 31
São Paulo 29
Boardman 26
Redondo Beach 24
Dallas 23
Haiphong 22
Buffalo 20
Lawrence 20
Helsinki 19
Amsterdam 16
Da Nang 16
Des Moines 16
Council Bluffs 15
Frankfurt am Main 15
Mexico City 15
Millbury 15
Boston 14
London 12
Montreal 12
Orem 12
Warsaw 12
Bari 11
Chicago 11
Poplar 11
Stockholm 11
Turku 11
Bologna 10
Chennai 10
Nuremberg 9
Seattle 9
Valencia 9
Brooklyn 8
Falkenstein 8
Florence 8
Genoa 8
Hải Dương 8
Madrid 8
Rio de Janeiro 8
Wilmington 8
Atlanta 7
Denver 7
Houston 7
Krefeld 7
Toronto 7
Biên Hòa 6
Casalnuovo di Napoli 6
Dublin 6
Düsseldorf 6
Guangzhou 6
San Francisco 6
Shanghai 6
Turin 6
Baghdad 5
Buenos Aires 5
Can Tho 5
Johannesburg 5
Lappeenranta 5
Phoenix 5
Salt Lake City 5
Trieste 5
Charlotte 4
Cilavegna 4
Long Xuyen 4
Monza 4
Ninh Bình 4
Portici 4
Sciacca 4
Tashkent 4
Tianjin 4
Vĩnh Long 4
Amman 3
Bad Durrheim 3
Bangkok 3
Belo Horizonte 3
Berlin 3
Bexley 3
Brasília 3
Brussels 3
Cuenca 3
Totale 3.561
Salva come PNG Salva come JPEG
Nome #
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 193
Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens 160
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 153
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 147
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 146
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 145
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 144
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 142
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 139
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 136
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 134
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 132
Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C‐mutated advanced non‐small cell lung cancer 132
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 131
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 129
Methods for actionable gene fusion detection in lung cancer: now and in the future 127
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 126
Next generation sequencing in cytology 126
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 125
The evolving role of liquid biopsy in lung cancer 124
The role of liquid biopsy in epithelial ovarian cancer: state of the art 121
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 120
Brca1/2 ngs somatic testing in clinical practice: a short report 120
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 119
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 117
BRAF: A Two-Faced Janus 116
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 115
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 115
Tumor mutational burden on cytological samples: A pilot study 113
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 113
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 110
Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study 109
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 109
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 108
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 105
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler 103
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma 99
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 99
Innovation in next-generation sequencing in non-Small cell lung cancer diagnostics 97
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls 95
The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study 95
Liquid biopsy testing in urological cancers: Focus on urine 90
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 90
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience 89
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 85
Critical aspects of MSI testing in endometrial cancer: a comparison study 84
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 83
Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer 74
Genomics and the early diagnosis of lung cancer 74
Smaller, cheaper, faster: where next for liquid biopsies? 72
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 69
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 63
Homologous recombination deficiency testing in ovarian cancer: the diagnostic experience of a referral Italian institution 62
Mutational profiling of SMARCA4 and SMARCB1 in ampullary adenocarcinoma: a preliminary study 51
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 49
Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience 36
The potential application of stroma modulation in targeting tumor cells: focus on pancreatic cancer and breast cancer models 34
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution 33
Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter Study 30
Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma 9
Totale 6.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 9 6 6
2021/2022173 6 5 12 2 3 3 3 15 1 25 55 43
2022/2023300 26 14 17 12 46 41 1 34 45 20 41 3
2023/2024301 10 42 17 16 20 18 13 34 17 33 40 41
2024/20251.598 54 58 6 17 38 92 141 115 81 205 586 205
2025/20263.838 350 449 438 390 705 210 404 239 436 217 0 0
Totale 6.266